Literature DB >> 2898126

The antinociceptive role of a bulbospinal serotonergic pathway in the rat brain.

M Y Liu1, C F Su, M T Lin.   

Abstract

The antinociceptive role of spinal serotonin (5-HT) neurons descending from 5-HT cells near the ventrolateral surface of the medulla oblongata was investigated by stimulating these cells in normal rats, in rats with generalized or selective chemical ablation of 5-HT nerves, and in rats with postsynaptic blockade of 5-HT receptors. Electrical stimulation of the lateral medulla elicited analgesia in normal rats; the increase in pain threshold was proportional to the intensity and to the frequency of stimulation. In addition, microinjection of kainic acid or L-glutamate at the same sites also produced analgesia. However, generalized destruction of CNS 5-HT nerves produced by intraventricular injection of 5,7-dihydroxytryptamine (5,7-DHT) or selective destruction of spinal 5-HT nerves produced by intraspinal injection of 5,7-DHT reduced the magnitude of the antinociceptive responses to electrical stimulation. Postsynaptic blockade of CNS 5-HT receptors produced by intraventricular injection of cyproheptadine also reduced the stimulation-produced analgesia. The specificity of the lesions for 5-HT nerves is demonstrated by the lack of effect on the levels of noradrenaline in the same brain regions. The results indicate that the activity of 5-HT nerve cells adjacent to the ventrolateral surface of the medulla oblongata and projecting to the spinal cord serves to elevate pain threshold.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898126     DOI: 10.1016/0304-3959(88)90211-4

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  9 in total

1.  Stimulation of 5-hydroxytryptamine nerve cells in dorsal and median raphe nuclei elevates blood glucose in rats.

Authors:  M T Lin; L R Shian
Journal:  Pflugers Arch       Date:  1991-01       Impact factor: 3.657

2.  Influence of repeated vitamin B administration on the frequency pattern analysed from rat brain electrical activity (Tele-Stereo-EEG).

Authors:  W Dimpfel; M Spüler; D Bonke
Journal:  Klin Wochenschr       Date:  1990-01-19

3.  Spinal cord stimulation in chronic pain: evidence and theory for mechanisms of action.

Authors:  Jacob Caylor; Rajiv Reddy; Sopyda Yin; Christina Cui; Mingxiong Huang; Charles Huang; Rao Ramesh; Dewleen G Baker; Alan Simmons; Dmitri Souza; Samer Narouze; Ricardo Vallejo; Imanuel Lerman
Journal:  Bioelectron Med       Date:  2019-06-28

Review 4.  Serotonin in pain and analgesia: actions in the periphery.

Authors:  Claudia Sommer
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

5.  Spinal 5-HT pathways and the antinociception induced by intramedullary clonidine in rats.

Authors:  M T Lin; C F Su
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

6.  Effect of intra-cisternal application of kainic acid on the spinal cord and locomotor activity in rats.

Authors:  Nilesh K Mitra; Tiffanie E W Goh; Thalisha Bala Krishnan; Vishna D Nadarajah; Arun K Vasavaraj; Tomoko Soga
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

7.  Stimulation of a bulbospinal 5-HT pathway in the rat brain produces hyperglycaemia.

Authors:  L R Shian; M T Lin
Journal:  Pflugers Arch       Date:  1990-07       Impact factor: 3.657

8.  Spinal cord stimulation modulates supraspinal centers of the descending antinociceptive system in rats with unilateral spinal nerve injury.

Authors:  Toshiharu Tazawa; Yoshinori Kamiya; Ayako Kobayashi; Kensuke Saeki; Masahito Takiguchi; Yusuke Nakahashi; Hironobu Shinbori; Kengo Funakoshi; Takahisa Goto
Journal:  Mol Pain       Date:  2015-06-24       Impact factor: 3.395

9.  Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model.

Authors:  Fei Shen; Pamela R Tsuruda; Jacqueline A M Smith; Glenmar P Obedencio; William J Martin
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.